An in-depth discussion on the targeting of specific molecular pathways with newer, novel therapies to better manage patients with liver cancer.
EP. 1: Optimizing Care for Patients With Hepatocellular Carcinoma
Watch
EP. 2: Hepatocellular Carcinoma Risk Stratification and Therapy
EP. 3: Testing for Targetable Mutations in Hepatocellular Carcinoma
EP. 4: Targeting the VEGF Pathway in Hepatocellular Carcinoma
EP. 5: HCC: VEGF TKI Data and Treatment Selection
EP. 6: PD-1/PD-L1 Antibodies and VEGF Inhibitors in HCC
EP. 7: Atezolizumab/Bevacizumab Data in Frontline HCC
EP. 8: Atezolizumab/Bevacizumab for HCC: Toxicity Management
EP. 9: Choosing Between VEGF TKIs for Frontline HCC Treatment
EP. 10: HCC Treatment After Previous I/O Therapy
EP. 11: Novel Combinations Under Study for HCC
EP. 12: Exciting Targets Under Study in HCC